NCT02725424 2022-08-17
MATCH
ChineseAMS
Phase 2 Completed
Clinical Trials
11 trialsNCT05218148 2022-04-06
SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma
ChineseAMS
Phase 2 Unknown
NCT04062058 2022-01-24
A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer
ChineseAMS
Phase 2 Unknown
NCT03415802 2021-02-01
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
ChineseAMS
Phase 2 Completed
NCT02301481 2019-10-16
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT03815461 2019-01-25
Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer
ChineseAMS
Phase 2 Unknown
NCT02947061 2016-10-31
S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT01980810 2016-06-14
GC-A-003
ChineseAMS
Phase 2 Terminated
NCT02370849 2015-02-25
Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT01531452 2014-12-04
The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer
ChineseAMS
Phase 2 Completed
NCT02296658 2014-11-20
A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer
ChineseAMS
Phase 2 Unknown